drug
as of 2026-07-01Sulpiride
Intramuscular Levosulpiride
at a glance
small molecule
Pre-approval / investigational in the US
Developed by Hannover Medical School
3 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
small molecule
Indications
Investigational (via trials)
SchizophreniaDepressionPsychosomatic DisordersSchizophrenia Spectrum and Other Psychotic DisordersAgitationPsychomotor AgitationSchizophreniaAnxiety DisordersDepressionPsychotic DisordersSchizoaffective DisordersPsychophysiologic DisordersDementiaAnxiety DisordersSchizophrenia and Disorders With Psychotic FeaturesDementia
Trials
3
Pharmacovigilance in Gerontopsychiatric Patients
NCT02374567Phase 3Terminated
Evaluation of the Necessity of Long-term Pharmacological Treatment With Antipsychotics in Schizophrenic Patients
NCT02307396Phase 4Completed
A Study To Evaluate The Efficacy And Safety Of Intramuscular Levosulpiride In Patients With Agitation Of Schizophrenia
NCT00866645Phase 2, Phase 3Completed
KOLs & investigators
4
Stefan Leucht, ProfessorKOL score 87
Helge Frieling, Prof., MDKOL score 5
Huafang Li, MD, PhDKOL score 3
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
company
trial
indication
indication
indication
indication
KOL
Stefan Leucht, Professor
personKOL score 87
Helge Frieling, Prof., MD
personKOL score 5
Huafang Li, MD, PhD
personKOL score 3
Markus Dold, MD
personKOL score —